Hulamin (HLM) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
6 Aug, 2026Executive summary
Turnover declined 6% to R7.0 billion for H1 2024, mainly due to lower volumes and export pricing pressure, but local market sales grew 77% year-on-year, now comprising 54-55% of total sales, driven by can body demand and a customer-centric strategy.
Strategic capital investment increased 114% to R302 million, focused on wide can body readiness, plant reliability, and growth markets.
Export demand recovered in late H1 2024 but was temporarily set back by a fire in the Coil Coating Line, with repairs on track for mid-September resumption.
Simplification strategy led to discontinuation of low-margin products, improving product mix but reducing volumes.
Strong local demand, especially in cans (67% of local sales), offset by continued export pressure and operational challenges in extrusions.
Financial highlights
Normalised EBIT fell 27% to R265 million year-on-year, but improved sequentially from H2 2023.
Normalised EBITDA declined 19% to R343 million year-on-year; margin at 4.9% (down from 5.7% in H1 2023).
Group revenue down 6% year-on-year to R6,967 million, but up 9% sequentially from H2 2023.
Net debt at R1,377 million, with debt to equity at 38.3%, up from 28.1% year-on-year, due to inventory build and capital investment.
Headline earnings per share dropped 17% to 79c; normalised HEPS down 38% to 43c.
Outlook and guidance
Local market conditions expected to remain resilient for the rest of 2024; export demand has recovered.
Export can end and tab production to resume mid-September after Coil Coating Line repairs.
Focus on reducing inventory to 44,000 tons by year-end to release cash flows and improve conversions.
Net debt reduction, working capital optimization, and cost control remain top priorities.
Management expects agility in H2 2024, focusing on high-margin products and cost containment.
Latest events from Hulamin
- EBITDA doubled and revenue rose 2% as operational recovery and asset disposals improved outlook.HLM
H1 2026 - EPS and headline EPS surged over 100% in H1 2026, despite lower normalised headline EPS.HLM
H1 2026 TU - All AGM resolutions passed; board addressed dividends, profitability, and strategic reviews.HLM
AGM 2025 - All AGM resolutions passed as shareholders pressed for faster turnaround and operational improvements.HLM
AGM 2026 - Revenue up 2% but EBIT down 77% amid operational setbacks; recovery expected in 2026.HLM
H2 2025 - Normalized EBIT fell 22% as sales volumes rose and capex surged, driving net debt higher.HLM
H2 2024 - Revenue up 8% but profit down 85% amid restructuring, cost pressures, and division exits.HLM
H1 2025